🧬 Neela Patel - Bonum Therapeutics - Part 4 | Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics

episode

The Biotech Startups Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Maris Kreizman reads "To Save Free Enterprise, Books Must Die" 6 min · 23 Sep 2026 · In Your Spare Time: From the Blog of Ursula K. Le Guin

7AM ET 09/23/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

BravoAndy and Bronwyn’s Fanny (Headlines) 1h 0m · 23 Sep 2026 · Two Ts In A Pod with Teddi Mellencamp and Tamra Judge

MIT Dethrones Princeton as America’s Top School & The Viral Debate Over Bringing Iced Coffee to Job Interviews 30 min · 23 Sep 2026 · Morning Brew Daily

The Spiral Explained 59 min · 23 Sep 2026 · Untraditionally Lala

US diesel dilemma 6 min · 23 Sep 2026 · Wall Street Breakfast

Report any issue

Source

Recorded31 Oct 2024

Publisherfeeds.fame.so ↗

Handlerec:3386486

Show notes

Part 4 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time at Bonum Therapeutics Neela worked as the CBO at Good Therapeutics, a biotech company that develops cutting edge protein-based drugs. Her impressive career also includes pivotal roles at Seattle Genetics, AbbVie, Abbott, and Genentech. Her extensive experience as both a scientist and business person give her unique insights you won’t want to miss.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in